Literature DB >> 8514874

Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha.

J J Costa1, K Matossian, M B Resnick, W J Beil, D T Wong, J R Gordon, A M Dvorak, P F Weller, S J Galli.   

Abstract

By in situ hybridization, 44-100% of the blood eosinophils from five patients with hypereosinophilia and four normal subjects exhibited intense hybridization signals for TNF-alpha mRNA. TNF-alpha protein was detectable by immunohistochemistry in blood eosinophils of hypereosinophilic subjects, and purified blood eosinophils from three atopic donors exhibited cycloheximide-inhibitable spontaneous release of TNF-alpha in vitro. Many blood eosinophils (39-91%) from hypereosinophilic donors exhibited intense labeling for macrophage inflammatory protein-1 alpha (MIP-1 alpha) mRNA, whereas eosinophils of normal donors demonstrated only weak or undetectable hybridization signals for MIP-1 alpha mRNA. Most tissue eosinophils infiltrating nasal polyps were strongly positive for both TNF-alpha and MIP-1 alpha mRNA. By Northern blot analysis, highly enriched blood eosinophils from a patient with the idiopathic hypereosinophilic syndrome exhibited differential expression of TNF-alpha and MIP-1 alpha mRNA. These findings indicate that human eosinophils represent a potential source of TNF-alpha and MIP-1 alpha, that levels of expression of mRNA for both cytokines are high in the blood eosinophils of hypereosinophilic donors and in eosinophils infiltrating nasal polyps, that the eosinophils of normal subjects express higher levels of TNF-alpha than MIP-1 alpha mRNA, and that eosinophils purified from the blood of atopic donors can release TNF-alpha in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514874      PMCID: PMC443331          DOI: 10.1172/JCI116506

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

Review 1.  The immunobiology of eosinophils.

Authors:  P F Weller
Journal:  N Engl J Med       Date:  1991-04-18       Impact factor: 91.245

2.  Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1.

Authors:  P F Weller; T H Rand; S E Goelz; G Chi-Rosso; R R Lobb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

3.  Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo.

Authors:  U Kyan-Aung; D O Haskard; R N Poston; M H Thornhill; T H Lee
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

4.  Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions.

Authors:  D Y Leung; J S Pober; R S Cotran
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

5.  Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.

Authors:  L J Walsh; G Trinchieri; H A Waldorf; D Whitaker; G F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha.

Authors:  B K Wershil; Z S Wang; J R Gordon; S J Galli
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules.

Authors:  B S Bochner; F W Luscinskas; M A Gimbrone; W Newman; S A Sterbinsky; C P Derse-Anthony; D Klunk; R P Schleimer
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

8.  Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses.

Authors:  J R Gordon; S J Galli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.

Authors:  R Moqbel; Q Hamid; S Ying; J Barkans; A Hartnell; A Tsicopoulos; A J Wardlaw; A B Kay
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

10.  Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils.

Authors:  H Kita; T Ohnishi; Y Okubo; D Weiler; J S Abrams; G J Gleich
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Liquiritin apioside attenuates laryngeal chemoreflex but not mechanoreflex in rat pups.

Authors:  Wan Wei; Xiuping Gao; Lei Zhao; Jianguo Zhuang; Yang Jiao; Fadi Xu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

3.  Regulation of eosinophil trafficking by SWAP-70 and its role in allergic airway inflammation.

Authors:  Nooshin S Bahaie; M Reza Hosseinkhani; Xiao Na Ge; Bit Na Kang; Sung Gil Ha; Malcolm S Blumenthal; Rolf Jessberger; Savita P Rao; P Sriramarao
Journal:  J Immunol       Date:  2011-12-30       Impact factor: 5.422

4.  Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.

Authors:  B Olszewska-Pazdrak; A Casola; T Saito; R Alam; S E Crowe; F Mei; P L Ogra; R P Garofalo
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions.

Authors:  Dai Miyazaki; Takao Nakamura; Masako Toda; Kam-Wa Cheung-Chau; Ricardo M Richardson; Santa Jeremy Ono
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

6.  Low-level laser therapy (LLLT) attenuates RhoA mRNA expression in the rat bronchi smooth muscle exposed to tumor necrosis factor-alpha.

Authors:  Flávia Mafra de Lima; Jan M Bjordal; Regiane Albertini; Fábio V Santos; Flavio Aimbire
Journal:  Lasers Med Sci       Date:  2010-09       Impact factor: 3.161

Review 7.  Alpha 4 integrin-induced cytokine production and eosinophil function.

Authors:  D H Broide
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.

Authors:  Anna-Lena Stenfeldt; Christine Wennerås
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  LPS-induced 111In-eosinophil accumulation in guinea-pig skin: evidence for a role for TNF-alpha.

Authors:  V B Weg; D T Walsh; L H Faccioli; T J Williams; M Feldmann; S Nourshargh
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue.

Authors:  S C Bischoff; A Lorentz; S Schwengberg; G Weier; R Raab; M P Manns
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.